Pituitary Tumor Clinical Trials & Research

Clinical trials are research studies that test new treatments to see how well they work. Our Pituitary and Skull Base Tumor Center is leading clinical trials investigating new medical therapies for patients with Cushing’s disease and acromegaly. They are also involved in quality-of-life studies aimed at improving long-term follow-up care for patients who need it.

Our experts can help determine which clinical trials are right for you. The following clinical trials for pituitary tumors are currently enrolling new patients.

To learn more about a particular study, choose from the list below. For more information about our research and clinical trials, call us at 212-639-3935, or talk with your doctor.

and/or
2 Clinical Trials found
A Phase 2 Study of Pasireotide in People With Prolactinoma
The purpose of this study is to see if the drug pasireotide works well to treat prolactinomas. Prolactinomas are noncancerous pituitary gland tumors that make too much prolactin. Prolactin is a hormone that causes the body to make less estrogen and testosterone (sex hormones).
New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau
Collecting Information about Treatment Results from Patients with Cushing's Syndrome
Cushing's syndrome occurs when the adrenal glands produce too much of the "stress hormone" known as cortisol. This can be caused by a tumor which develops in the pituitary gland and secretes a hormone called adrenocorticotropic hormone (ACTH). Cushing's syndrome can also be caused by an ACTH-secreting tumor elsewhere in the body, or by a tumor in the adrenal glands that makes cortisol.
New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau